BMS-387032   Click here for help

GtoPdb Ligand ID: 5670

Synonyms: BMS 387032 | BMS387032 | compound 21 [PMID: 15027863] | SNS 032 | SNS-032 | SNS032
PDB Ligand
Compound class: Synthetic organic
Comment: BMS-387032 was originally reported as a potent and selective inhibitor of cyclin-dependent kinase 2 [3]. It has subsequently been discovered to potently inhibit CDK7 and CDK9 [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 2
Rotatable bonds 7
Topological polar surface area 133.59
Molecular weight 380.13
XLogP 0.3
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES O=C(C1CCNCC1)Nc1ncc(s1)SCc1ncc(o1)C(C)(C)C
Isomeric SMILES O=C(C1CCNCC1)Nc1ncc(s1)SCc1ncc(o1)C(C)(C)C
InChI InChI=1S/C17H24N4O2S2/c1-17(2,3)12-8-19-13(23-12)10-24-14-9-20-16(25-14)21-15(22)11-4-6-18-7-5-11/h8-9,11,18H,4-7,10H2,1-3H3,(H,20,21,22)
No information available.
Summary of Clinical Use Click here for help
BMS-387032 (SNS-032) has completed Phase 1 evaluation in clinical trials in patients with advanced liquid and solid cancers, but development has not been advanced further. Click here to link to's full list of SNS-032 studies.